The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse
Gregory B. Lesinski(The Ohio State University), William E. Carson(Comprehensive Blood & Cancer Center)
Cited by 140
Related Papers
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
|Gut|2016|540
Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial
|Journal of Clinical Oncology|2004|415
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro
|Journal for ImmunoTherapy of Cancer|2019|181